Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Plasma carnitine levels vary with age, typically increasing until approximately 70 years before declining in parallel with reduced muscle mass and metabolic capacity
Multidistrict Litigation 3094 MDL 3094 refers to a multi-district litigation case consolidated in the Eastern District of Pennsylvania Federal Court against drug manufacturers Novo Nordisk (Ozempic, Wegovy, and Rybelsus) and Eli Lilly and Company (Trulicity and Mounjaro)
It is a non-selective agonist of MC1R, MC3R, MC4R, and MC5R with preferential activity at MC3R/MC4R
9 Amino Acids 848.82 Da (WAGGDASGE) Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Browse Research Guides Explore Research Library Research Use Only: All peptide and research compound products sold by Frontier Peptide Labs are intended exclusively for laboratory research and development purposes
